logo
SNPs and prognosis of GvHD before HCT: any progress?
Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives
A risk-adapted approach to acute GVHD to treatment: are we there yet?
Childhood to adult transition and long-term follow-up after blood and marrow transplantation
Early and late graft-failure after transplants
When is second allogeneic HSCT for relapse of acute leukaemia an option?
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes
Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome
Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT
Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center study
Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
Busulfan fludarabine vs busulfan cyclophosphamide as a preparative regimen before allogeneic hematopoietic cell transplantation: systematic review and meta-analysis
Geographic access to hematopoietic cell transplantation services in the United States
The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function
A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009–2013)
The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation
Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution
The use of basiliximab-infliximab combination for the treatment of severe gastrointestinal acute GvHD
Risk factors and impact of non- Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis: This article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue
Decreased pulmonary function in asymptomatic long-term survivors after allogeneic hematopoietic stem cell transplant
Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening
Allogeneic hematopoietic cell transplantation for severe aplastic anemia: similar long-term overall survival after transplantation with related donors compared to unrelated donors
Boosting humoral and cellular immunity to pneumococcus by vaccination before and just after autologous transplant for myeloma
New-onset food allergy following cord blood transplantation in adult patients
Monocyte recovery at day 100 is associated with improved survival in multiple myeloma patients who undergo allogeneic hematopoietic cell transplantation
Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer
Pericardial effusion post transplantation predicts inferior overall survival following allo-hematopoietic stem cell transplant
Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement
Pulmonary hypertension associated with bronchiolitis obliterans after hematopoietic stem cell transplantation
Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation
Unmanipulated haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in a patient with paroxysmal nocturnal hemoglobinuria and secondary aplastic anemia
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity
Risk factors and impact of non- Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis